Article
Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target mendelian randomization.
American journal of epidemiology - 2 Dec 2024
Woolf Benjamin, Cronjé Héléne T, Zagkos Loukas, Larsson Susanna C, Gill Dipender, Burgess Stephen
Abstract excerpt
Mendelian randomization is an epidemiologic technique that can explore the potential effect of perturbing a pharmacological target. Plasma caffeine levels can be used as a biomarker to measure the pharmacological effects of caffeine. Alternatively, this can be assessed using a behavioral proxy, such as average number of caffeinated drinks consumed per day. Either variable can be used as the exposure in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
